|
|
 |
|
CTIC: Cell Therapeutics Inc - Stock News |
Enter Ticker:
|
|
| Nov 20, 2009 |
Cell Therapeutics allowed to pursue USD22.8m claim against The Lash Group |
| Nov 20, 2009 |
CTIC: Wins Federal Court Appeal to Pursue $22.8 Million Claim vs The Lash Group |
| Nov 20, 2009 |
Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group |
| Nov 12, 2009 |
Stock research report available on Cell Therapeutics (NASDAQ:CTIC) from SmarTrend Analytics |
| Nov 06, 2009 |
Cell Therapeutics Down 15.9% Since SmarTrend's Sell Recommendation |
| Nov 05, 2009 |
Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45% |
| Nov 02, 2009 |
Trading Review for Cell Therapeutics Incorporated Issued by Beacon Equity |
| Nov 02, 2009 |
Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 5 |
| Oct 29, 2009 |
Cell Therapeutics, Inc.'s (CTI) Presentation at BIO Investor Forum to be Webcast |
| Oct 26, 2009 |
Cell Therapeutics Down 12.3% Since SmarTrend's Sell Recommendation |
| Oct 26, 2009 |
Cell Therapeutics, Inc. (CTI) to Present at 8th Annual BIO Investor Forum |
| Oct 22, 2009 |
BiomedReports: News and FDA Updates for Targacept (NASDAQ:TRGT), Cell Therapeutics (Nasdaq:CTIC) |
| Oct 22, 2009 |
Pixantrone Produces High Rates of Complete Remission in Multiple Relapsed and Refractory Indolent and Aggressive Non-Hodgkin's Lymphoma |
| Oct 21, 2009 |
BiomedReports: News and FDA Updates for Cell Therapeutics (Nasdaq:CTIC), Elan (NYSE:ELN) |
| Oct 21, 2009 |
Cell Therapeutics, Inc. Reports Outcome of Annual Meeting of Shareholders |
| |
| ZACKS COMMENTARY FOR CTIC |
| Nov 12, 2009 | Zacks Blog: CTIC Reports, Awaiting FDA Decision | | Sep 17, 2009 | Zacks Blog: Encouraging Data for Pixantrone | | Sep 08, 2009 | Zacks Blog: Cell Therapeutics Fails to Impress | | Sep 02, 2009 | Zacks Blog: NVS Ends NSCLC Drug Enrollment | | Aug 26, 2009 | Zacks Blog: Cell Therapeutics' Drug Accepted | | Jul 23, 2009 | Zacks Blog: Cell Therapeutics targets stock market | | Jul 14, 2009 | Zacks Blog: Cell Therapeutics Awaits Approval | | Jul 07, 2009 | Zacks Blog: CTIC Drug Awaits EMEA Approval | | Jun 29, 2009 | Zacks Blog: NSCLC Market to Reach $13 Billion by 2015 | | Jun 02, 2009 | Zacks Blog: Can Cell Therapeutics' Rally Last? | | Jun 01, 2009 | Zacks Analyst Interviews: Biotech Industry | | May 29, 2009 | Zacks Blog: Biotech Industry |
|
|
Sponsored Links 
-0.03